 |
4 Companies | 2 Products |
|
|
2 Products | |
13 Diseases | |
0 Trials |  |
29 News |  |
- | Journal: Development of Benzodioxine-heteroarylpiperazines as Highly Potent and Selective α2c Antagonists. (Pubmed Central) - Nov 16, 2022
No abstract available
- | Journal: 2,3-Dihydrobenzo-dioxine piperidine derivatives as potent and selective α2c antagonists. (Pubmed Central) - May 31, 2022
No abstract available In this manuscript, we report a series of benzodioxine methyl piperidine derivatives as highly potent and selective α2C antagonists by ligand design to improve the pharmacokinetics of a previous candidate molecule.